Post Holdings to Acquire National Pasteurized Eggs
Sep 01, 2016 12:00 pm UTC| Business
ST. LOUIS, Sept. 01, 2016 -- Post Holdings, Inc. (NYSE:POST) (“Post” or the “Company”), a consumer packaged goods holding company, today announced it has agreed to acquire National Pasteurized Eggs, Inc. (“NPE”). NPE...
Vera Bradley Announces Fiscal Second Quarter 2017 Results
Sep 01, 2016 12:00 pm UTC| Business
Second quarter net revenues totaled $119.2 million Gross profit rate expansion of 230 basis points Second quarter net income of $5.1 million, or $0.14 per share Company ended quarter with strong cash position and...
Paratek Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences
Sep 01, 2016 12:00 pm UTC| Business
BOSTON, Sept. 01, 2016 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that the company will participate in two upcoming investor conferences. Paratek is a biopharmaceutical company focused on the...
Sep 01, 2016 12:00 pm UTC| Business
PALO ALTO, Calif., Sept. 01, 2016 -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel San Francisco. ...
Aduro Biotech Announces New Corporate Offices and Laboratory Space
Sep 01, 2016 12:00 pm UTC| Business
BERKELEY, Calif., Sept. 01, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the opening of a new corporate office and laboratory facility, which will serve as the company’s new global headquarters for its U.S....
Achaogen Completes Patient Enrollment in Phase 3 EPIC Clinical Trial of Plazomicin
Sep 01, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2016 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
Sep 01, 2016 12:00 pm UTC| Business
WALTHAM, Mass., Sept. 01, 2016 -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...